Results 201 to 210 of about 189,433 (365)

Genetically‐targeted control of the spinal cord and peripheral nervous system

open access: yesJournal of Intelligent Medicine, EarlyView.
Application of genetically‐targeted stimulation for treating diseases or injuries outside the brain. Optogenetic and chemogenetic systems have been developed for dysfunction in the cochlea, spinal cord, dorsal root ganglia (DRGs), peripheral nerves, lower urinary tract, and enteric nervous system (ENS). Created with Biorender.com.
Anakaren Romero Lozano   +3 more
wiley   +1 more source

Current Biomarker Strategies in Autoimmune Neuromuscular Diseases. [PDF]

open access: yesCells, 2023
Oeztuerk M   +7 more
europepmc   +1 more source

Mouse p150Glued(Dynactin 1) cDNA Sequence and Evaluation as a Candidate for the Neuromuscular Disease Mutationmnd2

open access: hybrid, 1997
Wonhee Jang   +4 more
openalex   +1 more source

Protein defects in neuromuscular diseases [PDF]

open access: gold, 2003
Mariz Vainzof, Mayana Zatz
openalex   +1 more source

Reference Values for Water‐Specific T1, Intermuscular and Intramuscular Fat Content in Skeletal Muscle at 2.89 T

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
Background MRI offers quantification of proton density fat fraction (PDFF) and tissue characteristics with T1 mapping. The influence of age, sex, and the potential confounding effects of fat on T1 values in skeletal muscle in healthy adults are insufficiently known.
Stephen J. Foulkes   +7 more
wiley   +1 more source

The most bothersome symptoms in neuromuscular diseases: the ERN EURO NMD Survey. [PDF]

open access: yesOrphanet J Rare Dis
Mancuso M   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy